Overview
- ANMAT formalized the measure in Disposition 4919/2026 published on Thursday, August 13, 2026, which suspends Droguería Lomas S.A.’s authorization to perform interjurisdictional transit of medicines.
- The action grew out of a renewal inspection that found failures in Good Distribution Practices, including incomplete documentation, missing distribution records, and inadequate storage and transport controls.
- ANMAT gave the company a 15‑day window to correct the observations but says the firm submitted only partial evidence and did not fully prove remedial action, prompting the preventive suspension.
- A sanitary sumario was opened to determine administrative responsibility, ANMAT ordered updates to its registries and notified provincial health authorities, and the firm may file administrative appeals under the set deadlines.
- The suspension bars Droguería Lomas from moving medicines between jurisdictions until it proves full compliance, which could interrupt the firm’s deliveries and requires demonstrable fixes to paperwork, traceability and handling systems before service can resume.